MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells
- PMID: 25104088
- DOI: 10.1007/s13277-014-2412-0
MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells
Abstract
MicroRNAs (miRNAs) are emerging as critical regulators in carcinogenesis and tumor progression. Recently, miR-486-5p has been proved to play an important role in several cancers, but its functions in the context of breast cancer (BC) remain unknown. In this study, we found that miR-486-5p expression is significantly downregulated in BC tissues and cell lines. Overexpression of miR-486-5p dramatically suppressed BC cell proliferation in vitro and in vivo, induced G0/G1 arrest, and promoted apoptosis. We subsequently identified the oncogene PIM-1 as a direct target of miR-486-5p in BC. Overexpression of PIM-1 attenuated the function of miR-486-5p in BC cells. Together, we conclude that miR-486-5p exerts its antiproliferative function by directly downregulating PIM-1 expression. This novel miR-486-5p/PIM-1 axis provides insight into the pathogenesis of BC and might be therapeutic targets for prevention or treatment of BC.
Similar articles
-
Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.Bioengineered. 2021 Dec;12(1):9046-9057. doi: 10.1080/21655979.2021.1993715. Bioengineered. 2021. PMID: 34657558 Free PMC article.
-
Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.Thorac Cancer. 2020 Mar;11(3):619-630. doi: 10.1111/1759-7714.13306. Epub 2020 Jan 21. Thorac Cancer. 2020. PMID: 31962380 Free PMC article.
-
DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.Mol Carcinog. 2019 Apr;58(4):461-473. doi: 10.1002/mc.22941. Epub 2018 Dec 21. Mol Carcinog. 2019. PMID: 30457164
-
Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.Thorac Cancer. 2020 Jul;11(7):1891-1903. doi: 10.1111/1759-7714.13475. Epub 2020 May 23. Thorac Cancer. 2020. PMID: 32445273 Free PMC article.
-
MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.Yonsei Med J. 2019 Feb;60(2):148-157. doi: 10.3349/ymj.2019.60.2.148. Yonsei Med J. 2019. PMID: 30666836 Free PMC article.
Cited by
-
Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.PLoS One. 2015 Mar 20;10(3):e0119384. doi: 10.1371/journal.pone.0119384. eCollection 2015. PLoS One. 2015. PMID: 25793394 Free PMC article.
-
MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions.Noncoding RNA Res. 2020 Jan 9;5(1):11-21. doi: 10.1016/j.ncrna.2020.01.001. eCollection 2020 Mar. Noncoding RNA Res. 2020. PMID: 31993547 Free PMC article. Review.
-
Role of microRNA-486-5p as Biomarker Response in Cell Line K562 of Chronic Myeloid Leukemia.Asian Pac J Cancer Prev. 2025 Apr 1;26(4):1181-1187. doi: 10.31557/APJCP.2025.26.4.1181. Asian Pac J Cancer Prev. 2025. PMID: 40302069 Free PMC article.
-
MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.Am J Cancer Res. 2015 Sep 15;5(10):3015-29. eCollection 2015. Am J Cancer Res. 2015. PMID: 26693056 Free PMC article.
-
miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.Oncotarget. 2016 Mar 29;7(13):15840-53. doi: 10.18632/oncotarget.7417. Oncotarget. 2016. PMID: 26895105 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical